Market revenue in 2023 | USD 67.3 million |
Market revenue in 2030 | USD 86.9 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Remote medication management |
Fastest growing segment | Remote Medication Management |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Activity Monitoring, Remote Medication Management |
Key market players worldwide | Teladoc Health Inc, Abbott Laboratories, Johnson & Johnson, AstraZeneca PLC, Roche Holding AG ADR, Novartis AG ADR, Bristol-Myers Squibb Co, GlaxoSmithKline, Merck & Co Inc, Pfizer Inc, Sanofi SA, Samsung Electronics Co Ltd, Qualcomm Inc, Orange SA, Alphabet Inc Class A, Airstrip Technologies, AT&T, Apple Inc, Allscripts Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to telecare market will help companies and investors design strategic landscapes.
Remote medication management was the largest segment with a revenue share of 52.3% in 2023. Horizon Databook has segmented the Italy telecare market based on activity monitoring, remote medication management covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy telecare market, including forecasts for subscribers. This country databook contains high-level insights into Italy telecare market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account